|
1
|
Tamai T, Hayato S, Hojo S, Suzuki T,
Okusaka T, Ikeda K and Kumada H: Dose finding of lenvatinib in
subjects with advanced hepatocellular carcinoma based on population
pharmacokinetic and exposure-response analyses. J Clin Pharmacol.
57:1138–1147. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Q, Zhao S, Pang X and Chi B:
MicroRNA-381 suppresses cell growth and invasion by targeting the
liver receptor homolog-1 in hepatocellular carcinoma. Oncol Rep.
35:1831–1840. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Simoneau E, Hassanain M, Madkhali A,
Salman A, Nudo CG, Chaudhury P and Metrakos P:
(18)F-Fluorodeoxyglucose positron-emission tomography could have a
prognostic role in patients with advanced hepatocellular carcinoma.
Curr Oncol. 21:e551–e556. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patel A and Sun W: Molecular targeted
therapy in hepatocellular carcinoma: From biology to clinical
practice and future. Curr Treat Options Oncol. 15:380–394. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chappell G, Kutanzi K, Uehara T, Tryndyak
V, Hong HH, Hoenerhoff M, Beland FA, Rusyn I and Pogribny IP:
Genetic and epigenetic changes in fibrosis-associated
hepatocarcinogenesis in mice. Int J Cancer. 134:2778–2788. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martincorena I and Campbell PJ: Somatic
mutation in cancer and normal cells. Science. 349:1483–1489. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gawin B, Niederfuhr A, Schumacher N,
Hummerich H, Little PF and Gessler M: A 7.5 Mb sequence-ready PAC
contig and gene expression map of human chromosome 11p13-p14.1.
Genome Res. 9:1074–1086. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu W and He X: DEEP insights through the
DEP domain. Structure. 18:1223–1225. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Consonni SV, Maurice MM and Bos JL: DEP
domains: Structurally similar but functionally different. Nat Rev
Mol Cell Biol. 15:357–362. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tauriello DV, Jordens I, Kirchner K,
Slootstra JW, Kruitwagen T, Bouwman BA, Noutsou M, Rudiger SG,
Schwamborn K, Schambony A, et al: Wnt/beta-catenin signaling
requires interaction of the dishevelled DEP domain and C terminus
with a discontinuous motif in frizzled. Proc Natl Acad Sci USA.
109:pp. E812–E820. 2012, View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang XR, Yang H and Liao ZJ: Structure and
function of the DEP domain. Chemistry of Life. 35:264–271.
2015.
|
|
12
|
Liao ZJ, Ma WL, Liang S, Meng W, Shang T
and Zheng WL: Transcriptional regulation of genes involved in
liver-selective cell communication. Nan Fang Yi Ke Da Xue Xue Bao.
28:1582–1585. 2008.PubMed/NCBI
|
|
13
|
Kahng YS, Lee YS, Kim BK, Park WS, Lee JY
and Kang CS: Loss of heterozygosity of chromosome 8p and 11p in the
dysplastic nodule and hepatocellular carcinoma. J Gastroenterol
Hepatol. 18:430–436. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L, Chen W, Liang Y, Ma H, Li W, Zhou Z,
Li J, Ding Y, Ren J, Lin J, et al: The Gbetagamma-Src signaling
pathway regulates TNF-induced necroptosis via control of necrosome
translocation. Cell Res. 24:417–432. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meng QC, Wang HC, Song ZL, Shan ZZ, Yuan
Z, Zheng Q and Huang XY: Overexpression of NDC80 is correlated with
prognosis of pancreatic cancer and regulates cell proliferation. Am
J Cancer Res. 5:1730–1740. 2015.PubMed/NCBI
|
|
17
|
Dai J, Wu W, Zhou J, Gao K, Hu G, Lin C,
Zhang Y and Li X: Effect of antisense microRNA targeting survivin
on rectal cancer HRC-9698 cells and its mechanism. Int J Clin Exp
Pathol. 8:6057–6063. 2015.PubMed/NCBI
|
|
18
|
Su H, Ma C, Liu J, Li N, Gao M, Huang A,
Wang X, Huang W and Huang X: Downregulation of nuclear receptor FXR
is associated with multiple malignant clinicopathological
characteristics in human hepatocellular carcinoma. Am J Physiol
Gastrointest Liver Physiol. 303:G1245–G1253. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wurmbach E, Chen YB, Khitrov G, Zhang W,
Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, et
al: Genome-wide molecular profiles of HCV-induced dysplasia and
hepatocellular carcinoma. Hepatology. 45:938–947. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liao ZJ, Wang XR, Yang H and Zeng YT:
Effects of shRNA-mediated knockdown of DEPDC7 on proliferation,
migration and invasion of human hepatoma cell HepG2. Chin J Cell
Biol. 37:977–983. 2015.
|
|
21
|
Lopez-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum
Pathol. 40:1512–1515. 2009. View Article : Google Scholar : PubMed/NCBI
|
